Using Amyloids to Create Long-Acting Drugs
Author Information
Author(s): Samir K. Maji, David Schubert, Catherine Rivier, Soon Lee, Jean E. Rivier, Roland Riek
Primary Institution: The Salk Institute for Biological Studies
Hypothesis
Amyloids can be used as stable depots for the controlled release of long-acting peptide drugs.
Conclusion
Amyloids can effectively serve as a source for the sustained release of biologically active peptides, enhancing the duration of action of certain drugs.
Supporting Evidence
- Amyloids can act as stable reservoirs for peptide drugs.
- Long-acting GnRH analogs formed amyloid fibrils that released peptides slowly.
- Subcutaneous injection of amyloid-forming GnRH analogs resulted in prolonged drug action.
Takeaway
Researchers found that special protein structures called amyloids can help medicines work longer by slowly releasing the active parts of the drug.
Methodology
The study involved testing a family of GnRH analogs for their ability to form amyloids and their release profiles in vitro and in vivo.
Potential Biases
Potential bias in the selection of GnRH analogs and their testing conditions.
Limitations
The study primarily focused on a specific class of peptide drugs and may not be generalizable to all peptide or protein drugs.
Participant Demographics
Adult male Sprague-Dawley rats were used for in vivo experiments.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website